Customized carrier surface modifications using high-affinity ligands (including proprietary antibodies, peptides, and aptamers) to achieve ultra-high specificity enrichment for tumors, inflamed tissues, and specific cell subpopulations.
Targeting Delivery for Therapeutics
Advanced therapeutics—including cell, gene, and nucleic acid products—represent the frontier of medicine. Their efficacy relies entirely on one challenge: delivering complex payloads safely, efficiently, and specifically to target cells to ensure stable, long-term therapeutic effects. Creative Biolabs provides targeted delivery technology development services, focusing on nanocarrier engineering and bio-barrier penetration, offering breakthrough solutions to improve efficacy and reduce toxicity for your therapeutic pipeline.
Click Here to View more about our Service
What is Targeted Delivery?
Targeted delivery of advanced therapeutics is the critical strategy overcoming the limitations of conventional administration for complex biological and genetic payloads. This involves engineering sophisticated carriers to transport molecules like mRNA, siRNA, or even cell products directly to the required cells. Delivery systems maximize therapeutic concentration by using active targeting moieties and ensuring payloads successfully cross physiological barriers, including the cell membrane and endosome, which is paramount for functional gene editing or protein expression.
Fig.1 Gene delivery methods in gene therapy.1
Applications for Therapeutics
Gene/Nucleic Acid Therapy
LNP Platform provides a highly efficient, organ-specific LNP delivery system for nucleic acid drugs such as mRNA vaccines, siRNA, and ASO, ensuring stable expression.
Oncology Products
Delivery of gene editing tools, oncolytic viruses, or highly potent cytotoxic drugs to achieve precise tumor removal; Synergistic delivery to reverse multidrug resistance.
Chronic & Inflammatory Diseases
Targeting inflammatory cells (such as macrophages and lymphocytes) to achieve precise, low-dose, and low-side-effect anti-inflammatory treatment; long-term delivery: encapsulating biotherapeutics for sustained release over several months for chronic disease management.
Central Nervous System (CNS) Diseases
Developing advanced blood-brain barrier (BBB) delivery systems for neurodegenerative diseases and CNS tumors, critical for large molecule and gene payloads.
Delivery Challenges of Therapeutics
- Payload Specificity & Off-Target Effects: Many effective genetic products lack cell specificity, leading to damage to healthy tissues and limiting safe clinical dosage.
- Poor Biological Barrier Permeability: Especially for large molecules and nanocarriers, it is difficult to penetrate the BBB, gastrointestinal tract, or the dense extracellular matrix of tumors.
- In vivo Stability & Immunogenicity: Active biomolecules (peptides, nucleic acids) are easily degraded; carrier materials may trigger host immune responses, leading to rapid clearance by the mononuclear phagocytic system.
- Translational Complexity: Developing complex formulations requires robust, reproducible, and scalable manufacturing processes that meet stringent cGMP guidelines.
What We Can Offer
We offer professional targeted delivery technologies, focusing on solving the challenges of efficacy, stability, and targeting in the advanced therapeutics field:
Nucleic Acid Delivery LNP Optimization
We provide a highly tunable LNP platform, optimizing ionized lipid components and significantly improving the critical endosome escape efficiency of mRNA/siRNA within target cells for maximal gene expression.
Breakthrough Barrier Permeation Technology
We develop specialized BBB shuttle carriers and design enzyme-responsive carriers for penetrating the dense tumor matrix, delivering payloads to targets inaccessible by traditional systemic methods.
Long-Acting Controlled Release & PK Optimization
We design implantable and injectable sustained-release systems (such as PLGA microspheres and sophisticated liposomal gels) that effectively extend the duration of therapeutic action to weeks or even months.
Why Choose Us?
Clinical Translation Expertise
We specialize in the complex engineering and regulatory support required to bridge the "bench-to-bedside" gap.
Proprietary Platform
Access to optimized, proven carrier libraries and advanced aptamer conjugation technologies.
Multimodal Solutions
Expertise across passive, active, smart, and biological delivery systems, including revolutionary exosome engineering.
Workflow
Elevate your therapeutic pipeline from concept to clinical viability. Contact us today to schedule a confidential consultation and discover how precision delivery can redefine your success.
Reference
- Moaveni, Amir Kian, et al. "Advances and challenges in gene therapy strategies for pediatric cancer: a comprehensive update." Frontiers in Molecular Biosciences 11 (2024): 1382190. Distributed under Open Access license CC BY 4.0, without modification. https://doi.org/10.3389/fmolb.2024.1382190
Our services are For Research Use Only. We do not provide services to individuals.
Online Inquiry
